US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 2.310
  • -0.050-2.12%
Close Mar 28 16:00 ET
  • 2.310
  • 0.0000.00%
Post 20:01 ET
688.35MMarket Cap-4.20P/E (TTM)

AbCellera Biologics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-24.17%28.83M
-44.98%5.05M
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-92.17%38.03M
-57.40%9.18M
-93.49%6.6M
-78.10%10.06M
-96.15%12.19M
Operating revenue
-24.17%28.83M
-44.98%5.05M
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-92.17%38.03M
-57.40%9.18M
-93.49%6.6M
-78.10%10.06M
-96.15%12.19M
Cost of revenue
0
0
Gross profit
-24.17%28.83M
-90.92%38.03M
Operating expense
26.39%329.98M
3.35%74.26M
64.81%96.68M
71.39%97.47M
-16.45%61.57M
36.03%261.08M
28.10%71.86M
26.25%58.66M
19.55%56.87M
76.30%73.69M
Selling and administrative expenses
13.72%85.49M
0.47%19.16M
24.92%22.28M
20.48%23.33M
9.58%20.72M
12.62%75.18M
21.44%19.07M
5.66%17.84M
10.44%19.36M
13.63%18.91M
-Selling and marketing expense
-9.88%12.78M
1.42%3.14M
-9.60%3.14M
-18.35%3.14M
-10.77%3.37M
25.82%14.18M
15.20%3.1M
12.27%3.47M
23.11%3.84M
59.11%3.77M
-General and administrative expense
19.20%72.71M
0.29%16.02M
33.25%19.15M
30.09%20.19M
14.66%17.35M
9.94%61M
22.74%15.97M
4.18%14.37M
7.69%15.52M
6.07%15.13M
Research and development costs
-4.78%167.26M
-5.24%46.08M
8.05%40.97M
12.21%40.93M
-25.38%39.29M
62.83%175.66M
72.14%48.62M
42.64%37.92M
36.68%36.47M
99.68%52.65M
Depreciation amortization depletion
272.41%90.85M
66.73%12.57M
543.75%36.92M
551.02%36.52M
-12.15%4.84M
-12.38%24.4M
-45.46%7.54M
11.36%5.74M
14.82%5.61M
38.20%5.51M
-Depreciation and amortization
272.41%90.85M
66.73%12.57M
543.75%36.92M
551.02%36.52M
-12.15%4.84M
-12.38%24.4M
-45.46%7.54M
11.36%5.74M
14.82%5.61M
38.20%5.51M
Other operating expenses
3.78%-13.62M
-4.98%-3.54M
-23.44%-3.49M
27.67%-3.31M
2.93%-3.28M
-34.12%-14.16M
-101.55%-3.38M
-31.53%-2.83M
-198.11%-4.58M
35.04%-3.37M
Operating profit
-35.01%-301.15M
-10.42%-69.21M
-73.20%-90.17M
-92.56%-90.14M
16.07%-51.62M
-198.23%-223.05M
-73.61%-62.68M
-230.53%-52.06M
-582.31%-46.81M
-126.72%-61.5M
Net non-operating interest income expense
-8.93%38.47M
-20.98%8.67M
-10.59%9.6M
-9.07%9.8M
6.58%10.4M
162.75%42.25M
29.50%10.97M
93.30%10.74M
662.31%10.78M
1,367.52%9.76M
Non-operating interest income
-8.93%38.47M
-20.98%8.67M
-10.59%9.6M
-9.07%9.8M
6.58%10.4M
162.75%42.25M
29.50%10.97M
93.30%10.74M
662.31%10.78M
1,367.52%9.76M
Other net income (expense)
819.10%62.28M
341.53%13.71M
776.69%17.94M
1,732.28%32.16M
-142.55%-1.53M
267.52%6.78M
182.19%3.11M
78.53%2.05M
-36.90%-1.97M
3.59M
Other non- operating income (expenses)
819.10%62.28M
341.53%13.71M
776.69%17.94M
1,732.28%32.16M
-142.55%-1.53M
267.52%6.78M
182.19%3.11M
78.53%2.05M
-36.90%-1.97M
--3.59M
Income before tax
-15.15%-200.4M
3.65%-46.83M
-59.47%-62.63M
-26.79%-48.19M
11.22%-42.75M
-172.79%-174.03M
-54.72%-48.6M
-184.31%-39.28M
-451.90%-38M
-120.86%-48.15M
Income tax
-35.85%-37.54M
-769.08%-12.62M
-8.05%-11.53M
-50.58%-11.26M
73.41%-2.14M
-134.29%-27.63M
4.41%-1.45M
-153.43%-10.67M
-7,301.98%-7.48M
-112.92%-8.04M
Net income
-11.24%-162.86M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
Net income continuous Operations
-11.24%-162.86M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
Minority interest income
Net income attributable to the parent company
-11.24%-162.86M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.24%-162.86M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
Basic earnings per share
-7.84%-0.55
35.29%-0.11
-70.00%-0.17
-18.18%-0.13
0.00%-0.14
-191.07%-0.51
-70.00%-0.17
-211.11%-0.1
-450.00%-0.11
-123.73%-0.14
Diluted earnings per share
-7.84%-0.55
35.29%-0.11
-70.00%-0.17
-18.18%-0.13
0.00%-0.14
-202.00%-0.51
-70.00%-0.17
-225.00%-0.1
-450.00%-0.11
-125.93%-0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -24.17%28.83M-44.98%5.05M-1.39%6.51M-27.18%7.32M-18.36%9.95M-92.17%38.03M-57.40%9.18M-93.49%6.6M-78.10%10.06M-96.15%12.19M
Operating revenue -24.17%28.83M-44.98%5.05M-1.39%6.51M-27.18%7.32M-18.36%9.95M-92.17%38.03M-57.40%9.18M-93.49%6.6M-78.10%10.06M-96.15%12.19M
Cost of revenue 00
Gross profit -24.17%28.83M-90.92%38.03M
Operating expense 26.39%329.98M3.35%74.26M64.81%96.68M71.39%97.47M-16.45%61.57M36.03%261.08M28.10%71.86M26.25%58.66M19.55%56.87M76.30%73.69M
Selling and administrative expenses 13.72%85.49M0.47%19.16M24.92%22.28M20.48%23.33M9.58%20.72M12.62%75.18M21.44%19.07M5.66%17.84M10.44%19.36M13.63%18.91M
-Selling and marketing expense -9.88%12.78M1.42%3.14M-9.60%3.14M-18.35%3.14M-10.77%3.37M25.82%14.18M15.20%3.1M12.27%3.47M23.11%3.84M59.11%3.77M
-General and administrative expense 19.20%72.71M0.29%16.02M33.25%19.15M30.09%20.19M14.66%17.35M9.94%61M22.74%15.97M4.18%14.37M7.69%15.52M6.07%15.13M
Research and development costs -4.78%167.26M-5.24%46.08M8.05%40.97M12.21%40.93M-25.38%39.29M62.83%175.66M72.14%48.62M42.64%37.92M36.68%36.47M99.68%52.65M
Depreciation amortization depletion 272.41%90.85M66.73%12.57M543.75%36.92M551.02%36.52M-12.15%4.84M-12.38%24.4M-45.46%7.54M11.36%5.74M14.82%5.61M38.20%5.51M
-Depreciation and amortization 272.41%90.85M66.73%12.57M543.75%36.92M551.02%36.52M-12.15%4.84M-12.38%24.4M-45.46%7.54M11.36%5.74M14.82%5.61M38.20%5.51M
Other operating expenses 3.78%-13.62M-4.98%-3.54M-23.44%-3.49M27.67%-3.31M2.93%-3.28M-34.12%-14.16M-101.55%-3.38M-31.53%-2.83M-198.11%-4.58M35.04%-3.37M
Operating profit -35.01%-301.15M-10.42%-69.21M-73.20%-90.17M-92.56%-90.14M16.07%-51.62M-198.23%-223.05M-73.61%-62.68M-230.53%-52.06M-582.31%-46.81M-126.72%-61.5M
Net non-operating interest income expense -8.93%38.47M-20.98%8.67M-10.59%9.6M-9.07%9.8M6.58%10.4M162.75%42.25M29.50%10.97M93.30%10.74M662.31%10.78M1,367.52%9.76M
Non-operating interest income -8.93%38.47M-20.98%8.67M-10.59%9.6M-9.07%9.8M6.58%10.4M162.75%42.25M29.50%10.97M93.30%10.74M662.31%10.78M1,367.52%9.76M
Other net income (expense) 819.10%62.28M341.53%13.71M776.69%17.94M1,732.28%32.16M-142.55%-1.53M267.52%6.78M182.19%3.11M78.53%2.05M-36.90%-1.97M3.59M
Other non- operating income (expenses) 819.10%62.28M341.53%13.71M776.69%17.94M1,732.28%32.16M-142.55%-1.53M267.52%6.78M182.19%3.11M78.53%2.05M-36.90%-1.97M--3.59M
Income before tax -15.15%-200.4M3.65%-46.83M-59.47%-62.63M-26.79%-48.19M11.22%-42.75M-172.79%-174.03M-54.72%-48.6M-184.31%-39.28M-451.90%-38M-120.86%-48.15M
Income tax -35.85%-37.54M-769.08%-12.62M-8.05%-11.53M-50.58%-11.26M73.41%-2.14M-134.29%-27.63M4.41%-1.45M-153.43%-10.67M-7,301.98%-7.48M-112.92%-8.04M
Net income -11.24%-162.86M27.44%-34.21M-78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M-207.46%-28.61M-349.93%-30.53M-123.79%-40.11M
Net income continuous Operations -11.24%-162.86M27.44%-34.21M-78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M-207.46%-28.61M-349.93%-30.53M-123.79%-40.11M
Minority interest income
Net income attributable to the parent company -11.24%-162.86M27.44%-34.21M-78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M-207.46%-28.61M-349.93%-30.53M-123.79%-40.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.24%-162.86M27.44%-34.21M-78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M-207.46%-28.61M-349.93%-30.53M-123.79%-40.11M
Basic earnings per share -7.84%-0.5535.29%-0.11-70.00%-0.17-18.18%-0.130.00%-0.14-191.07%-0.51-70.00%-0.17-211.11%-0.1-450.00%-0.11-123.73%-0.14
Diluted earnings per share -7.84%-0.5535.29%-0.11-70.00%-0.17-18.18%-0.130.00%-0.14-202.00%-0.51-70.00%-0.17-225.00%-0.1-450.00%-0.11-125.93%-0.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More